FULL PAPERS
FEDER). We gratefully acknowledge computational time
provided by the Centro de Computaciꢀn Cientꢁfica at the
Universidad Autꢀnoma de Madrid CCC-UAM.
T. Knauber, C.-J. Li, Angew. Chem. 2014, 126, 76;
Angew. Chem. Int. Ed. 2014, 53, 74; g) R. Narayan, K.
Matcha, A. P. Antonchick, Chem. Eur. J. 2015, 21,
1
4678.
11] Selected recent examples: a) C.-J. Li, Acc. Chem. Res.
009, 42, 335; b) A. G. Condie, J. C. Gonzalez-Gomez,
[
2
References
C. R. Stephenson, J. Am. Chem. Soc. 2010, 132, 1464;
c) E. Boess, D. Sureshkumar, A. Sud, C. Wirtz, C.
Fares, M. Klussmann, J. Am. Chem. Soc. 2011, 133,
[
1] Some reviews: a) J. H. Shah, R. M. Hindupur, H. N.
Pati, Curr. Bioact. Compd. 2015, 11, 170; b) J. H. Ryan,
C. Hyland, J. Just, A. G. Meyer, J. A. Smith, C. C. Wil-
liams, Heterocycl. Chem. 2013, 25, 455; c) J.-P. K.
Meigh, Science of Synthesis, (Eds.: S. M. Weinreb, E.
Schaumann), Thieme, Stuttgart, 2004, Vol. 17, p 825.
2] See for example: a) C. C. Tenn, L. P. Niles, J. Pharma-
col. Exp. Ther. 1995, 274, 84; b) D. La Torre, A. Falorni,
Ther. Clin. Risk Manag. 2007, 3, 929; Y. Yu, J. Wang,
P. H. Sun, Y. Guo, Z. Zhang, G. Jin, X. J. Zhen, Neuro-
chemistry 2008, 104, 946; c) S. Sarkar, S. M. Husain, D.
Schepmann, R. Frçhlich, B. Wꢅnsch, Tetrahedron 2012,
8
106; d) E. Boess, C. Schmitz, M. Klussmann, J. Am.
Chem. Soc. 2012, 134, 5317; e) Q.-H. Zheng, W. Meng,
G. J. Jiang, Z.-X. Yu, Org. Lett. 2013, 15, 5928; f) G.
Zhang, X. Ma, G. Cheng, D. Liu, R. Wang, Org. Lett.
2
014, 16, 656; g) C. Min, A. Sanchawala, D. Seidel,
[
Org. Lett. 2014, 16, 2756; h) H. Ueda, K. Yoshida, H.
Tokuyama, Org. Lett. 2014, 16, 4194; i) T. Wang, M.
Schrempp, A. Berndhauser, O. Schiemann, D. Menche,
Org. Lett. 2015, 17, 3982; j) Q. Chen, J. Zhou, Y. Wang,
C. Wang, X. Liu, Z. Xu, L. Lin, R. Wang, Org. Lett.
2
015, 17, 4212.
6
8, 2687.
[
3] Selected examples: a) D. P. Behan, B. M. Smith, C.
Bjenning, WO Patent WO/2006/071740, 2006; b) S. Mo-
hapatra, M. R. Hellberg, Z. Feng, U.S. Patent 0293475,
[12] a) W. Ando, H. Miyazaki, K. Ito, D. Auchi, Tetrahedron
Lett. 1982, 23, 555; b) T. Aoyama, T. Shioiri, Tetrahe-
dron Lett. 1986, 27, 2005; c) T. Nojima, K. Ishiguro, Y.
Sawaki, J. Org. Chem. 1997, 62, 6911.
2
007; c) I. Shimada, K. Maeno, Y. Kondoh, H. Kaku,
K. Sugasawa, Y. Kimura, K. Hatanaka, Y. Naitou, F.
Wanibuchi, S. Sakamoto, S. Tsukamoto, Bioorg. Med.
Chem. 2008, 16, 3309.
[13] T. Stopka, L. Marzo, M. Zurro, S. Janich, E. U.
Wꢅrthwein, C. G. Daniliuc, J. Alemꢁn, O. Garcꢂa Man-
cheÇo, Angew. Chem. 2015, 127, 5137; Angew. Chem.
Int. Ed. 2015, 54, 5049.
[
4] a) B. Smith, J. Smith, 5HT2C receptor modulators. U.S.
Patent 6,953,787, 2005; D. Nikolic, P. P. Toth, A. Ferlita,
V. D. Bartolo, G. Montalto, M. Banach, M. Rizzo, Clin.
Lipidol. 2014, 9, 179; b) Q. Zhu, J. Wang, X. Bian, L.
Zhang, P. Wei, Y. Xu, Org. Process Res. Dev. 2015, 19,
[14] For a review on expansions to 7-membered rings: E. J.
Kantorowski, M. J. Kurth, Tetrahedron 2000, 56, 4317.
[15] Ring expansion of isoquinolium salts with CH N : a) T.
2
2
Kametani, M. S. Premila, S. Hirata, H. Seto, H.
Nemoto, K. Fukumoto, Can. J. Chem. 1975, 53, 3824;
b) for a 2-step synthesis, see: T. Xiao, L. Li, G. Lin, Z.-
W. Mao, L. Zhou, Org. Lett. 2014, 16, 4232; for a ring
expansion of sulfonylimines with diazomethanes: c) A.-
J. Xia, T.-R. Kang, L. He, L.-M. Chen, W.-T. Li, J.-L.
Yang, Q.-Z. Liu, Angew. Chem. 2016, 128, 1463;
Angew. Chem. Int. Ed. 2016, 55, 1441; d) for a recent
Ag-catalyzed 3-component reaction, see: T. Xiao, P.
Peng, Y. Xie, Z.-Y. Wang, L. Zhou, Org. Lett. 2015, 17,
1
263.
[
5] See for example: a) M. B. Murphy, C. Murray, G. D. N.
Shorten, N. Engl. J. Med. 2001, 345, 1548; b) W. C.
Oliver, G. A. Nuttall, K. J. Cherry, P. A. Decker, T.
Bower, M. H. Ereth, Anesth. Analg. 2006, 103, 833.
6] See for example: J. C. Tardif, I. Ford, M. Tendera,
M. G. Bourassa, K. Fox, Eur. Heart J. 2005, 26, 2529.
7] For some recent examples based on a Friedel–Crafts
reaction, see: a) M. Bandini, M. Tragni, A. Umani-
Ronchi, Adv. Synth. Catal. 2009, 351, 2521; b) R. B.
Kargbo, Z. Sajjadi. Hashemi, S. Roy, X. Jin, R. J. Herr,
Tetrahedron Lett. 2013, 54, 2018; c) M. Mizukami, K.
Wada, G. Sato, Y. Ishii, N. Kawahara, S. Nagumo, Tet-
rahedron 2013, 69, 4120.
8] First synthesis of 3-benzazepines: a) K. Dimroth, H.
Freyschlag, Angew. Chem. 1956, 68, 518. See also:
b) M.-Y. Chang, C.-K. Chan, S.-Y. Lin, R.-T. Hsu, Tet-
rahedron 2012, 68, 10272; c) B. W. Burbaum, C. A.
Gilson, S. Aytes, S. A. Estrada, D. Sengupta, B. Smith,
M. Rey, U. Weigl, WO Patent WO 2005019179, 2005.
9] A. ꢆlvarez-Pꢀrez, C. Gonzꢁlez-Rodrꢂguez, C. Garcꢂa-
Yebra, J. A. Varela, E. OÇate, M. A. Esteruelas, C. Saꢁ,
Angew. Chem. 2015, 127, 13555; Angew. Chem. Int. Ed.
[
[
4
332.
[
[
16] For example: a) M. A. Mercadante, C. B. Kelly, J. M.
Bobbitt, L. J. Tilley, N. E. Leadbeater, Nat. Protoc.
2
013, 8, 666; b) O. Garcꢂa MancheÇo, T. Stopka, Syn-
thesis 2013, 45, 1602.
[
17] TEMPO salt oxidants in C–H functionalization: a) S.
Wetz, S. Kodama, A. Studer, Angew. Chem. 2011, 123,
1
1713; Angew. Chem. Int. Ed. 2011, 50, 11511; b) H.
Richter, R. Frçhlich, C. G. Daniliuc, O. Garcꢂa Man-
cheÇo, Angew. Chem. 2012, 124, 8784; Angew. Chem.
Int. Ed. 2012, 51, 8656; c) C. Yan, Y. Liu, Q. Wang,
RSC Adv. 2014, 4, 60075; d) S. Sun, C. Li, P. E. Florean-
cig, H. Lou, L. Liu, Org. Lett. 2015, 17, 1684.
[
[
18] CCDC 1453370 contains the supplementary crystallo-
graphic data for compound 3q in this paper. These data
2
015, 54, 13357.
10] Selected reviews: a) C. J. Scheuermann, Chem. Asian J.
010, 5, 436; b) M. Klussmann, D. Sureshkumar, Syn-
[
2
thesis 2011, 353; c) C. S. Yeung, V. M. Dong, Chem.
Rev. 2011, 111, 1215; d) C. Liu, H. Zhang, W. Shi, A.
Lei, Chem. Rev. 2011, 111, 1780; e) R. Rohlmann, O.
Garcꢂa MancheÇo, Synlett 2013, 24, 6; f) S. A. Girard,
[19] C. D. Perchonock, J. A. Finkelstein, J. Org. Chem. 1980,
45, 2000.
Adv. Synth. Catal. 0000, 000, 0 – 0
7
ꢄ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ÞÞ
These are not the final page numbers!